San Francisco, California
BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients with unmet needs. Founded in 2015 by a team of industry veterans, the company has built a portfolio of 20 transformative drugs ranging from pre-clinical to late-stage development in multiple therapeutic areas including genetic dermatology, oncology, cardiology, neurology, endocrinology, renal disease, and ophthalmology. The company’s focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have offices in San Francisco, Palo Alto, Boston, New York, and Raleigh, with small satellites in other parts of the country.
To learn more, visit us at
Who You Are:
Do you want to be a part of the next-level discovery team to test “moonshots” in genetic disease at BridgeBio? We seek an entrepreneurial Scientist to work on these high-risk, high-reward programs within a culture that celebrates failures, as long as they were scientifically rigorous and conclusive. The projects within this team need someone with deep knowledge in biochemistry and molecular biology and expertise in cutting-edge techniques in sequencing, microscopy, iPSCs, structural biology, etc.
You will lead and contribute to discovery and development assays for some of the most challenging and high-impact genetic diseases and bring our early discovery, pre-clinical programs to the next level. Suppose you have expertise in developing and optimizing various biophysical, biochemical, molecular, and cellular assays and want to be on the ground floor to build this internal capability at BridgeBio. In that case, we want to hear from you.
Education, Experience & Skills Requirements:
What We Offer:
We will not accept unsolicited resumes from agencies. Please do not send agency resumes to our website or BridgeBio and affiliating employees.